The Tolerability and Effects of AZD0530 in Individuals With or Without a Family History of Alcoholism
NCT02262026
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
49
Enrollment
OTHER
Sponsor class
Conditions
Alcoholism
Interventions
DRUG:
125 mg AZD0530
DRUG:
50 mg AZD0530
DRUG:
Placebo
Sponsor
Yale University